Keybank National Association OH Has $235,000 Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO)

Posted by on Aug 25th, 2023

Keybank National Association OH lowered its stake in AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) by 9.0% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 22,775 shares of the medical instruments supplier’s stock after selling 2,250 shares during the period. Keybank National Association OH owned approximately 0.06% of AngioDynamics worth $235,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Point72 Hong Kong Ltd acquired a new position in AngioDynamics in the 1st quarter valued at about $36,000. CWM LLC grew its position in shares of AngioDynamics by 1,048.0% during the 4th quarter. CWM LLC now owns 2,032 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 1,855 shares in the last quarter. Captrust Financial Advisors grew its position in shares of AngioDynamics by 95.1% during the 1st quarter. Captrust Financial Advisors now owns 2,883 shares of the medical instruments supplier’s stock worth $62,000 after purchasing an additional 1,405 shares in the last quarter. Tower Research Capital LLC TRC grew its position in shares of AngioDynamics by 187.1% during the 3rd quarter. Tower Research Capital LLC TRC now owns 4,442 shares of the medical instruments supplier’s stock worth $91,000 after purchasing an additional 2,895 shares in the last quarter. Finally, UBS Group AG grew its position in shares of AngioDynamics by 764.3% during the 3rd quarter. UBS Group AG now owns 5,670 shares of the medical instruments supplier’s stock worth $116,000 after purchasing an additional 5,014 shares in the last quarter. Institutional investors and hedge funds own 92.82% of the company’s stock.

AngioDynamics Stock Performance

Shares of AngioDynamics stock opened at $8.43 on Friday. The company has a 50 day moving average of $9.35 and a 200-day moving average of $10.20. AngioDynamics, Inc. has a 1-year low of $8.06 and a 1-year high of $23.32. The company has a current ratio of 1.95, a quick ratio of 1.29 and a debt-to-equity ratio of 0.13. The company has a market cap of $334.42 million, a PE ratio of -6.39 and a beta of 0.61.

AngioDynamics (NASDAQ:ANGO – Get Free Report) last issued its quarterly earnings results on Wednesday, July 12th. The medical instruments supplier reported $0.02 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.02. AngioDynamics had a negative net margin of 15.48% and a negative return on equity of 0.61%. The company had revenue of $91.10 million during the quarter, compared to the consensus estimate of $90.73 million. During the same quarter in the prior year, the firm posted $0.01 EPS. The firm’s quarterly revenue was up 4.7% on a year-over-year basis. As a group, equities research analysts forecast that AngioDynamics, Inc. will post -0.32 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have issued reports on ANGO shares. Canaccord Genuity Group increased their target price on shares of AngioDynamics from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Thursday, July 13th. StockNews.com started coverage on shares of AngioDynamics in a research report on Thursday, August 17th. They set a “hold” rating on the stock.

Read Our Latest Report on ANGO

AngioDynamics Company Profile

(Free Report)

AngioDynamics, Inc provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease.

Featured Articles

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.